Lexology October 10, 2023
Reed Smith LLP

We can sum up the claim in Telebrands Corp. v. Luminas Int’l LLC, like this—hey court, it’s not fair that I’m following the FDA’s rules and my competitors are not, so you should force them to do so to even the playing field. 2023 U.S. Dist. LEXIS 179285 (S.D. Cal. Jul. 12, 2023). To which the court appropriately said—you’ve come to the wrong place; FDA rules are the FDA’s to enforce. In other words, all your claims are impliedly preempted and so they are dismissed without leave to amend.

Plaintiff is an online seller of over-the-counter analgesic patches used for pain relief. Plaintiff has listed its patches on the FDA’s National Drug Code (“NDC”) database. Id. at *2. Doing so...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article